Early metabolic response assessment of breast cancer liver metastases: 4-week posttreatment FDG PET predicts survival after 90Y microsphere radioembolization

MLA

Amir Sabet, et al. “Early Metabolic Response Assessment of Breast Cancer Liver Metastases: 4-Week Posttreatment FDG PET Predicts Survival after 90Y Microsphere Radioembolization.” Nuklearmedizin, vol. 58, June 2019, pp. 242–48. EBSCOhost, https://doi.org/10.1055/a-0891-7650.

APA

Amir Sabet, Martin Ries, Christian Rudlowski, Birgit Simon, Carsten Meyer, Fadi Khreish, Samer Ezziddin, & Yamen Al-Khalaf. (2019). Early metabolic response assessment of breast cancer liver metastases: 4-week posttreatment FDG PET predicts survival after 90Y microsphere radioembolization. Nuklearmedizin, 58, 242–248. https://doi.org/10.1055/a-0891-7650

Chicago

Amir Sabet, Martin Ries, Christian Rudlowski, Birgit Simon, Carsten Meyer, Fadi Khreish, Samer Ezziddin, and Yamen Al-Khalaf. 2019. “Early Metabolic Response Assessment of Breast Cancer Liver Metastases: 4-Week Posttreatment FDG PET Predicts Survival after 90Y Microsphere Radioembolization.” Nuklearmedizin 58 (June): 242–48. doi:10.1055/a-0891-7650.